Langerhans Cell Histiocytosis and Mastocytosis: A Rare Association
Keywords:
Langerhans Cell Histiocytosis, Mastocytosis, Rare Association, Case Report, Clinical FeaturesReferences
Haupt R, Minkov M, Astigarraga I, et al. Langerhans cell histiocytosis (LCH): guidelines for diagnosis, clinical work-up, and treatment for patients till the age of 18 years. Pediatr Blood Cancer. 2013;60(2):175-184. DOI:10.1002/pbc.24367
Valent P, Akin C, Hartmann K, et al. Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal. Hemasphere. 2021;5(11):e646. Published 2021 Oct 13. DOI:10.1097/HS9.0000000000000646).
Carlos Rodriguez-Galindo and Carl E. Allen. Langerhans cell histiocytosis. Blood. 2020 Apr 16;135(16):1319-1331. DOI: 10.1182/blood.2019000934.
Laura Polivka, Julien Rossignol, Antoine Neuraz et al. Criteria for the regression of pediatric mastocytosis: a long-term follow-up. The Journal of Allergy and Clinical Immunology: In Practice. Volume 9, Issue 4, April 2021 Pages 1695-1704.e5. DOI: 10.1016/j.jaip.2020.12.019.
Lozano Masdemont B, Campos Dominguez M, Gomez-Recuero Munoz L, Moreno Garcia B, Parra Blanco V, Suarez Fernandez R. Congenital cutaneous Langerhans cell histiocytosis and cutaneous mastocytoma in a child. Dermatol Online J. 2016;22(4). DOI: 13030/qt4kv9x9rh.
Published
Issue
Section
License
Copyright (c) 2025 Romain Boisseau, Lea Scaramuzzino, Grégory Bosphore, Kim Heang Ly
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.
How to Cite
Share
